Application 220314
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SEMAGLUTIDE | SEMAGLUTIDE | INJECTION;SOLUTION | 2MG/3ML | No | No |
| 002 | SEMAGLUTIDE | SEMAGLUTIDE | INJECTION;SOLUTION | 4MG/3ML | No | No |
| 003 | SEMAGLUTIDE | SEMAGLUTIDE | INJECTION;SOLUTION | 8MG/3ML | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 42bdd912-2393-44c4-b7e0-47672ca28991 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | SEMAGLUTIDE |
| WEGOVY | SEMAGLUTIDE | A-S Medication Solutions | f5e548d0-cc79-4c34-a3f5-e20a5b8b6564 | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | SEMAGLUTIDE |
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 979e4df4-0597-48ea-b51c-0f699fa6d166 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | SEMAGLUTIDE |
| OZEMPIC | SEMAGLUTIDE | A-S Medication Solutions | e6da837c-0da0-41d6-973c-5559bf764367 | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | SEMAGLUTIDE |